Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.836
Bid: 0.836
Ask: 0.842
Change: -0.002 (-0.24%)
Spread: 0.006 (0.718%)
Open: 0.838
High: 0.842
Low: 0.836
Prev. Close: 0.838
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

27 Dec 2017 07:00

RNS Number : 2713A
BioPharma Credit PLC
27 December 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

BioPharma Credit PLC

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Issue of New Shares

Yes

3. Full name of person(s) subject to thenotification obligation: iii

Inteligo Bank Ltd.

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

18 December 2017

6. Date on which issuer notified:

21 December 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

8%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD USD0.01

Below 9%

Below 9%

78,525,801

78,525,801

0

8.59%

0.0%

GB00BDGKMY29

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

 

N/A

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

78,525,801

8.59%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Victor Vinatea / Guillermo Villanueva

15. Contact telephone number:

+507-366-9602 / +507-366-9670

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUVORBRAUUAA
Date   Source Headline
5th Oct 20226:15 pmRNSTransaction in Own Shares
4th Oct 20226:15 pmRNSTransaction in Own Shares
3rd Oct 20226:15 pmRNSTransaction in Own Shares
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20226:15 pmRNSTransaction in Own Shares
29th Sep 20226:15 pmRNSTransaction in Own Shares
28th Sep 20226:15 pmRNSTransaction in Own Shares
27th Sep 20226:15 pmRNSTransaction in Own Shares
26th Sep 20226:15 pmRNSTransaction in Own Shares
23rd Sep 20226:15 pmRNSTransaction in Own Shares
22nd Sep 20226:15 pmRNSTransaction in Own Shares
22nd Sep 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Sep 20226:15 pmRNSTransaction in Own Shares
16th Sep 20226:15 pmRNSTransaction in Own Shares
15th Sep 20226:15 pmRNSTransaction in Own Shares
14th Sep 20227:00 amRNSHalf-yearly Report
14th Sep 20227:00 amRNSSTATEMENT RE SAREPTA THERAPEUTICS, INC.
31st Aug 20227:00 amRNSNotice of Half Year Results
22nd Aug 20224:53 pmRNSStatement re Epizyme
19th Aug 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
16th Aug 20227:00 amRNSDividend Declaration
9th Aug 20227:00 amRNSSTATEMENT RE GLOBAL BLOOD THERAPEUTICS
21st Jul 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Jul 202211:11 amRNSStatement Re Akebia
11th Jul 20227:00 amRNSTransaction in Own Shares
8th Jul 20227:00 amRNSTransaction in Own Shares
6th Jul 20225:36 pmRNSTransaction in Own Shares
5th Jul 20225:40 pmRNSTransaction in Own Shares
1st Jul 20227:00 amRNSSHARE BUY-BACK PROGRAMME
28th Jun 20227:00 amRNSSTATEMENT RE EPIZYME
23rd Jun 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
9th Jun 20225:39 pmRNSResult of AGM
23rd May 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
13th May 202212:35 pmRNSNotice of AGM
5th May 202210:25 amRNSDirector/PDMR Shareholding
27th Apr 20225:15 pmRNSDividend Declaration
26th Apr 202211:36 amRNSHolding(s) in Company
25th Apr 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Apr 20223:18 pmRNSResults of Placing in BioPharma Credit Plc
20th Apr 20227:00 amRNSProposed Secondary Placing in BioPharma Credit Plc
22nd Mar 20227:00 amRNSAnnual Financial Report
21st Mar 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Mar 20222:17 pmRNSNOTICE OF FULL YEAR RESULTS
8th Mar 20224:30 pmRNSNEW INVESTMENT
24th Feb 20223:58 pmRNSDividend Declaration
21st Feb 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Feb 20224:37 pmRNSDirector/PDMR Shareholding
14th Feb 202212:30 pmRNSUS$325 MILLION INVESTMENT IN COLLEGIUM
24th Jan 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Jan 20227:00 amRNSNEW INVESTMENT OF UP TO US$150.0 MILLION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.